Clinical Trial Update: Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating VERU-944 to reduce hot flashes in men with metastatic prostate cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• VERU-944 (VERU-944)

Snippet

Sponsor: Veru Inc. | Conditions: Prostate Cancer Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2021-06-18